Ultrabac 8

Manufacturer: Pfizer Animal Health

Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Sordellii-Perfringens Types C & D Bacterin-Toxoid

U.s. Vet. Lic. No.

189

Description

ULTRABAC^® 8 consists of killed, standardized cultures of Cl. chauvoei, Cl. septicum, Cl. haemolyticum, Cl. novyi, Cl. sordellii, and Cl. perfringens types C and D, with an adjuvant.

Ultrabac 8 Indications

For use in healthy cattle and sheep as an aid in preventing blackleg caused by Clostridium chauvoei, malignant edema caused by Cl. septicum, bacillary hemoglobinuria caused by Cl. haemolyticum, black disease caused by Cl. novyi, gas-gangrene caused by Cl. sordellii, and enterotoxemia and enteritis caused by Cl. perfringens types B, C, and D. Although Cl. perfringens type B is not a significant problem in North America, immunity is provided by the beta toxoid of type C and the epsilon toxoid of type D.

Directions

Shake well.

Cattle: Aseptically administer 5 mL subcutaneously, followed by a second dose 4-6 weeks later. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (SC) under the skin.

Sheep: Aseptically administer 21/2 mL subcutaneously, followed by a second dose 4-6 weeks later. For Cl. haemolyticum, repeat the dose every 5-6 months in animals subject to reexposure. Annual revaccination with a single dose is recommended.

Precaution(s)

Store at 2°-7°C. Do not freeze.

Use entire contents when first opened.

Ultrabac 8 Caution(s)

As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.

Warning(s)

Do not vaccinate within 21 days before slaughter.

For veterinary use only.

85-4387-04

Presentation

10 dose, 50 dose, and 200 dose plastic vials. Color coded labels.

Nac No.

36900250